Original Article
Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers
Yu Zhang, Xiaojie Peng, Kaizhou Jin, Wei Wang, Xingyu Feng, Yujie Zeng, Minhu Chen, Xianjun Yu, Ye Chen, Jie Chen
Published 2016-11-25
Cite as Chin J Gastrointest Surg, 2016, 19(11): 1235-1240. DOI: 10.3760/cma.j.issn.1671-0274.2016.11.008
Abstract
ObjectiveTo investigate the clinicopathological characteristics and their relationship with prognosis of colorectal neuroendocrine neoplasms (NEN) .
MethodsMedical records of 329 patients with colorectal NEN between June 2001 and July 2016 from 6 large scale centers in China were reviewed to investigate the clinicopathological characteristics and their relationship with prognosis of colorectal NEN.
Results(1) Colonic NEN: A total of 41 patients with colonic NEN were enrolled from The First Affiliated Hospital of Sun Yat-sen University (n= 11) , Sun Yat-sen University Cancer Center (n= 15) , Guangdong General Hospital (n= 10) , Sun Yet-san Memorial Hospital of Sun Yat-sen University (n= 3) and Fudan University Shanghai Cancer Center (n= 2) . 41 cases, including 20 males and 21 females with a mean age of (58.7 ± 4.7) years. Twenty-three colonic NEN originated in hindgut (23/41, 56.1%) , and 20 patients were stage Ⅳ (20/41, 48.8%) . Nine cases (22.0%) were neuroendocrine tumor (NET) , 25 (61.0%) were neuroendocrine carcinoma (NEC) and 7 (17.1%) were mixed adenoendocrine carcinoma (MANEC) . Six cases (14.6%) were G1 grade, 3 (7.3%) were G2 grade and 32 (78.1%) were G3 grade. Ulcerative or cauliflower-like tumors were the most common appearance under endoscopy (both 9/41, 22.0%) . Thirty-three patients (80.5%) underwent surgery. During follow-up, 19 cases died and the 3-year survival rate was 46.1%. Multivariate analysis revealed that stage Ⅳ was an independent risk factor of poor prognosis (HR= 3.871, 95%CI: 1.342 to 11.167, P= 0.012) in colonic NEN patients. (2) Rectal NEN: A total of 288 patients with rectal NEN were enrolled from The First Affiliated Hospital of Sun Yat-sen University (n= 130) , Nanfang Hospital of Southern Medical University (n= 115) and Fudan University Shanghai Cancer Center (n= 43) . Two hundred and eighty-eight cases, including 181 males and 107 females with a mean age of (47.7 ± 1.5) years. One hundred and ninety-seven patients were stage Ⅰ (197/288, 68.4%) . Of 288 rectal NEN cases, 267 (92.7%) were NET, 20 (7.0%) were NEC and 1 (0.3%) was MANEC; 214 (74.3%) were G1 grade, 53 (18.4%) were G2 grade and 21 (7.3%) were G3 grade. Submucosal tumor was the most common appearance under endoscopy (164/288, 56.9%) . Most of the rectal NET G1/G2 tumors were submucosal (146/214, 68.2%; 18/53, 34.0% respectively) while most of G3 tumors were cauliflower-like (14/21, 66.7%) . A total of 175 patients (60.8%) underwent endoscopic therapy, while 96 patients (33.3%) underwent surgery. During follow-up, 12 cases died and 3-year survival rate was 94.0%. Multivariate analysis revealed that poor differentiation as NEC or MANEC (HR= 8.919, 95% CI: 1.911 to 41.637, P= 0.005) and stage Ⅲ to Ⅳ (HR= 10.304, 95% CI: 1.772 to 59.916, P= 0.009) were independent risk factors of poor prognosis in rectal NEN patients.
ConclusionsThe clinicopathological manifestations of rectal NEN and colonic NEN are quite different. Rectal NEN are more common with better differentiation and has better prognosis than colonic NEN.
Key words:
Colonic neuroendocrine neoplasms; Rectal neuroendocrine neoplasms; Clinical manifestations; Endoscopic features; Prognosis
Contributor Information
Yu Zhang
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
Xiaojie Peng
Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
Kaizhou Jin
Pancreatic Cancer Institute, Fudan University
Department of Pancreatic Oncology, Shanghai Cancer Center, Fudan University, Shanghai 200032, China
Wei Wang
Department of Gastric and Pancreatic Surgery, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
Xingyu Feng
Department of General Surgery, Guangdong General Hospital, Guangzhou 510080, China
Yujie Zeng
Department of Biliary-Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
Minhu Chen
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
Xianjun Yu
Pancreatic Cancer Institute, Fudan University
Department of Pancreatic Oncology, Shanghai Cancer Center, Fudan University, Shanghai 200032, China
Ye Chen
Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
Jie Chen
Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China